Jenkins TM - Search Results

1

Effects of CYP3A4 inducers with and without CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers.

Abel S, Jenkins TM, Whitlock LA, Ridgway CE, Muirhead GJ. Abel S, et al. Among authors: jenkins tm. Br J Clin Pharmacol. 2008 Apr;65 Suppl 1(Suppl 1):38-46. doi: 10.1111/j.1365-2125.2008.03134.x. Br J Clin Pharmacol. 2008. PMID: 18333864 Free PMC article. Clinical Trial.

2

Population pharmacokinetic/pharmacodynamic analysis of CCR5 receptor occupancy by maraviroc in healthy subjects and HIV-positive patients.

Rosario MC, Jacqmin P, Dorr P, James I, Jenkins TM, Abel S, van der Ryst E. Rosario MC, et al. Among authors: jenkins tm. Br J Clin Pharmacol. 2008 Apr;65 Suppl 1(Suppl 1):86-94. doi: 10.1111/j.1365-2125.2008.03140.x. Br J Clin Pharmacol. 2008. PMID: 18333870 Free PMC article.

3

Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.

Fätkenheuer G, Pozniak AL, Johnson MA, Plettenberg A, Staszewski S, Hoepelman AI, Saag MS, Goebel FD, Rockstroh JK, Dezube BJ, Jenkins TM, Medhurst C, Sullivan JF, Ridgway C, Abel S, James IT, Youle M, van der Ryst E. Fätkenheuer G, et al. Among authors: jenkins tm. Nat Med. 2005 Nov;11(11):1170-2. doi: 10.1038/nm1319. Epub 2005 Oct 5. Nat Med. 2005. PMID: 16205738

4

Emergence of CXCR4-using human immunodeficiency virus type 1 (HIV-1) variants in a minority of HIV-1-infected patients following treatment with the CCR5 antagonist maraviroc is from a pretreatment CXCR4-using virus reservoir.

Westby M, Lewis M, Whitcomb J, Youle M, Pozniak AL, James IT, Jenkins TM, Perros M, van der Ryst E. Westby M, et al. Among authors: jenkins tm. J Virol. 2006 May;80(10):4909-20. doi: 10.1128/JVI.80.10.4909-4920.2006. J Virol. 2006. PMID: 16641282 Free PMC article. Clinical Trial.

5

Efficient assessment of efficacy in post-traumatic peripheral neuropathic pain patients: pregabalin in a randomized, placebo-controlled, crossover study.

Jenkins TM, Smart TS, Hackman F, Cooke C, Tan KK. Jenkins TM, et al. J Pain Res. 2012;5:243-50. doi: 10.2147/JPR.S34098. Epub 2012 Jul 27. J Pain Res. 2012. PMID: 22888270 Free PMC article.

6

Pre-clinical pharmacokinetics of UK-453,061, a novel non-nucleoside reverse transcriptase inhibitor (NNRTI), and use of in silico physiologically based prediction tools to predict the oral pharmacokinetics of UK-453,061 in man.

Allan G, Davis J, Dickins M, Gardner I, Jenkins T, Jones H, Webster R, Westgate H. Allan G, et al. Xenobiotica. 2008 Jun;38(6):620-40. doi: 10.1080/00498250802069088. Xenobiotica. 2008. PMID: 18570162

7

Activity, pharmacokinetics and safety of lersivirine (UK-453,061), a next-generation nonnucleoside reverse transcriptase inhibitor, during 7-day monotherapy in HIV-1-infected patients.

Fätkenheuer G, Staszewski S, Plettenburg A, Hackman F, Layton G, McFadyen L, Davis J, Jenkins TM. Fätkenheuer G, et al. Among authors: jenkins tm. AIDS. 2009 Oct 23;23(16):2115-22. doi: 10.1097/QAD.0b013e32832fef5b. AIDS. 2009. PMID: 19779321 Clinical Trial.

8

Molecular Classification Outperforms Histologic Classification in Prognostication of High-grade Endometrial Carcinomas With Undifferentiated and Sarcomatous Components.

Hammer PM, Wang A, Vermij L, Zdravkovic S, Heilbroner L, Ryan E, Geisick RLP, Charu V, Longacre TA, Suarez CJ, Ho C, Jenkins TM, Mills AM, Bosse T, Howitt BE. Hammer PM, et al. Among authors: jenkins tm. Am J Surg Pathol. 2024 May 23. doi: 10.1097/PAS.0000000000002250. Online ahead of print. Am J Surg Pathol. 2024. PMID: 38780000

9

Yolk Sac Differentiation in Endometrial Carcinoma: Incidence and Clinicopathologic Features of Somatically Derived Yolk Sac Tumors Versus Carcinomas With Nonspecific Immunoexpression of Yolk Sac Markers.

Mills AM, Jenkins TM, Dibbern ME, Atkins KA, Ring KL. Mills AM, et al. Among authors: jenkins tm. Am J Surg Pathol. 2024 Apr 23. doi: 10.1097/PAS.0000000000002230. Online ahead of print. Am J Surg Pathol. 2024. PMID: 38651612

10

(F)utility of preoperative pulmonary function testing in pectus excavatum to assess severity.

Gonzalez GC, Berazaluce AMC, Jenkins TM, Hardie WD, Foster KE, Moore RA, Powell AW, Garcia VF, Brown RL. Gonzalez GC, et al. Among authors: jenkins tm. Pediatr Surg Int. 2024 Apr 8;40(1):102. doi: 10.1007/s00383-024-05675-3. Pediatr Surg Int. 2024. PMID: 38589706 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

247 results

Search Page